Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Among Key Investor Topics in CNBC Morning Squawk SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms Riot Platforms Surges to New 52Week High Tapping 2593 Taiwan Emerges as Critical Unspoken Issue in TrumpXi Talks SoftBank Taps Banks for US IPOs of SB Energy and AI Robotics Spinoff Roze Sources Confirm Prediction Markets Signal Rising Odds of Fed Rate Hike by July 2027 Northeast Bank NBN Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Response COST Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressures Stock Declines Adamas Trust ADAML Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat on FixedtoFloating Rate Structure AVGO Q1 2026 Earnings A Slight EPS Miss Amidst Solid Operational Momentum Hexcel Corporation HXL Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Aerospace Demand Senmiao Technology Limited AIHS Q1 2026 Earnings Narrowed Loss Amid Operational Challenges TenLeague International TLIH Surges 10 as Bullish Momentum Builds Above Support John B Sanfilippo Son JBSS Rallies 238 as Support Holds Eyes Resistance at 8135 Evolent Health EVH Declines Nearly 3 as Shares Approach Key Support at 353 Laureate Education LAUR Gains 127 Approaches Key Resistance Zone Chicago Atlantic BDC LIEN Edges Lower in Quiet Session as Sector Positioning Remains Cautious Sun Pharma Share Price Key Factors Shaping the Stocks Recent Movement Chatham Lodging Trust CLDT Q1 2026 Earnings Narrowed Loss Beats Street Expectations Amid Challenging Conditions Voya Global Equity Dividend and Premium Opportunity Fund IGD Holds Steady at 635 BiomX Inc PHGE Q4 2025 Earnings EPS Misses by Wide Margin No Revenue Stock Declines NTCT Q1 2026 Earnings EPS Surpasses Estimates as Company Delivers Strong Profitability ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline Vistance Networks Inc VISN Q1 2026 Earnings EPS Surges Past Estimates with 7094 Surprise NAGE Q1 2026 Earnings EPS Beats Estimates by a Slim Margin Stock Declines Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares AKR Q1 2026 Earnings Earnings Beat by Wide Margin Despite Minor Stock Decline